1. Home
  2. SUNS vs FATE Comparison

SUNS vs FATE Comparison

Compare SUNS & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunrise Realty Trust Inc.

SUNS

Sunrise Realty Trust Inc.

N/A

Current Price

$7.55

Market Cap

108.7M

Sector

Real Estate

ML Signal

N/A

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

N/A

Current Price

$2.51

Market Cap

125.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SUNS
FATE
Founded
2023
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
108.7M
125.6M
IPO Year
2024
2013

Fundamental Metrics

Financial Performance
Metric
SUNS
FATE
Price
$7.55
$2.51
Analyst Decision
Hold
Buy
Analyst Count
1
6
Target Price
$8.75
$4.10
AVG Volume (30 Days)
80.0K
1.7M
Earning Date
05-14-2026
05-14-2026
Dividend Yield
16.17%
N/A
EPS Growth
N/A
29.88
EPS
0.54
N/A
Revenue
$21,571,434.00
$6,646,000.00
Revenue This Year
$70.81
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$14.09
N/A
Revenue Growth
102.96
N/A
52 Week Low
$7.34
$0.93
52 Week High
$11.78
$3.23

Technical Indicators

Market Signals
Indicator
SUNS
FATE
Relative Strength Index (RSI) 43.46 47.44
Support Level $7.38 $1.01
Resistance Level $8.18 $2.88
Average True Range (ATR) 0.23 0.18
MACD 0.01 -0.02
Stochastic Oscillator 42.40 40.00

Price Performance

Historical Comparison
SUNS
FATE

About SUNS Sunrise Realty Trust Inc.

Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS, and debt-like preferred equity securities across CRE asset classes and investment mix to include high-quality multi-family, condominiums, retail, office, hospitality, industrial, mixed-use, and specialty-use real estate. The company's portfolio is concentrated in the Southern U.S.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: